Live Nasdaq Composite: Tech Strength Lifts Markets
Tech-led gains paced a Nasdaq climb as investors reassessed hawkish Fed signals. The index rose, while traders weighe...
Ways To Make Extra Money To Pay Off Debt
Explore various ways to make extra money to help pay off debt. Start boosting your income and enhancing your finances!
22,417 articles
NBC’s Llamas Climbed From Intern to TV News Anchor
From a 15-year-old intern to NBC’s Nightly News anchor, this profile examines the financial lessons behind a high-pro...
Tanker Traffic Through Strait Rises to Post-Conflict High
Shipping lanes near the Strait of Hormuz see stronger flows as negotiations raise hopes for calmer seas. The uptick c...
HeartFlow NovoCure: Which Emerging Stock Is Best in 2026
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Everyone Talking About SpaceX? Two Growth Stocks I Prefer
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
Tesla Short Bets Rise as Michael Burry Bets Against Robots
Billionaire investor Michael Burry has lodged a new tesla short bet, intensifying the debate over Tesla’s robotics pu...
Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Cramer: Cheap Still Cheaper — Salesforce Skeptics Persist
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Trinidad Tobago Signs Deals for Data Centers
Trinidad and Tobago signed two memorandums of understanding with U.S. firms to move forward with large-scale data cen...
Trillion Anthropic Here’s Won’t: IPO Mania vs Reality
Anthropic’s rumored trillion-dollar IPO has investors buzzing, yet a wave of caution surrounds the offering amid valu...
Micron Delivers Strong Earnings, Elevates Full-Year Guidance
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status